购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • SGLT
    (8)
  • ATPase
    (1)
  • HIF
    (1)
  • Others
    (2)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (6)
  • 8-10周
    (1)
  • 3-6月
    (3)
筛选
搜索结果
TargetMol产品目录中 "

h-sglt2

"的结果
  • 抑制剂&激动剂
    10
    TargetMol | Inhibitors_Agonists
  • 天然产物
    1
    TargetMol | Natural_Products
  • Ertugliflozin L-pyroglutamic acid
    PF-04971729 L-pyroglutamic acid, 埃格列净 L-焦谷氨酸盐
    T152441210344-83-4
    Ertugliflozin L-pyroglutamic acid (PF-04971729 L-pyroglutamic acid) 是一种特异性和口服活性的 hSGLT2 抑制剂,IC50 为 0.877 nM。 Ertugliflozin L-pyroglutamic acid 可用于治疗 2 型糖尿病的研究。
    • ¥ 136
    现货
    规格
    数量
  • Dapagliflozin
    达格列净, BMS-512148
    T2389461432-26-8
    Dapagliflozin (BMS-512148) 是一种葡萄糖协同转运蛋白2 (SGLT2) 抑制剂,可与靶点竞争性结合。Dapagliflozin 可用于 2 型糖尿病的治疗,可以减少肾脏的葡萄糖重吸收,增加尿液中葡萄糖的排泄,从而降低血浆葡萄糖水平。
    • ¥ 349
    现货
    规格
    数量
    TargetMol | Citations 客户已引用
  • Canagliflozin
    卡格列净, TA 7284, JNJ 28431754AAA, JNJ 28431754, JNJ 24831754ZAE
    T1782842133-18-0
    Canagliflozin (JNJ 28431754AAA) 是一种选择性 SGLT2 抑制剂,抑制表达 mSGLT2、rSGLT2 和 hSGLT2 的 CHO 细胞 (IC50=2 3.7 4.4 nM)。Canagliflozin 可以用于治疗 Ⅱ 型糖尿病 (T2DM)。
    • ¥ 185
    现货
    规格
    数量
    TargetMol | Citations 客户已引用
  • SGL5213
    T128921240305-17-2
    SGL5213 is an oral active and low-absorbable inhibitor of sodium-dependent glucose cotransporter 1 (SGLT1)(hSGLT1 and hSGLT2 with IC50 values of 29 nM and 20 nM , respectively),and has potential to treat type 2 diabetes.
    • ¥ 26600
    3-6月
    规格
    数量
  • Mizagliflozin
    GSK-1614235 free base, KGA-3235 free base, DSP-3235 free base
    T16083666843-10-3
    Mizagliflozin 是口服有效的、选择性的 SGLT1抑制剂,对人 SGLT1 的 Ki 值为 27 nM。Mizagliflozin 对 SGLT1 的选择性是 SGLT2的303 倍。Mizagliflozin 是抗糖尿病药物,可以改善餐后血糖波动并有可能有改善慢性便秘的潜力。
    • ¥ 678
    现货
    规格
    数量
    TargetMol | Citations 客户已引用
  • SGLT inhibitor-1
    T128932247314-23-2
    SGLT inhibitor-1 is a potentsodium glucose co-transporter proteins (SGLTs) dual inhibitor(hSGLT1 and hSGLT2 with IC50s of 43 nM and 9 nM, respectively).
    • ¥ 18300
    3-6月
    规格
    数量
  • LX2761
    T157971610954-97-6
    LX2761 is a chemically stable and effective inhibitor against sodium-dependent glucose cotransporter 1 (SGLT1) and SGLT2 (IC50s: 2.2 nM and 2.7nM for hSGLT1 and hSGLT2). However, it shows specific SGLT1 inhibition in the gastrointestinal (GI) tract.
    • 待询
    3-6月
    规格
    数量
  • Phlorizin
    Floridzin, 根皮甙, 根皮苷, NSC 2833, Phloridzin
    T292260-81-1
    Phlorizin (Phloridzin) 是非选择性的SGLT 抑制剂,也是Na+ K+-ATPase 抑制剂,对于hSGLT1和hSGLT2的Ki 值分别为 300 和 39 nM。
    • ¥ 108
    现货
    规格
    数量
    TargetMol | Citations 客户已引用
  • Ertugliflozin
    埃格列净, PF-04971729, MK-8835
    T49991210344-57-2
    Ertugliflozin (PF-04971729) 是选择性的、口服有效的钠离子依赖的葡萄糖协同转运蛋白2 (SGLT2) 抑制剂,对h-SGLT2 的IC50值为 0.877 nM。Ertugliflozin 在2型糖尿病中有研究价值。
    • ¥ 446
    现货
    规格
    数量
  • YM-543 choline
    T703901610007-47-0
    YM-543, also known as ASP-543, is a selective SGLT2 inhibitor. Sodium-glucose cotransporter 2 (SGLT2) is a specifically expressed transporter in the kidney that plays an important role in renal glucose reabsorption, and its inhibition may present a novel therapeutic strategy for treating diabetes. YM543 potently and selectively inhibited mouse and human SGLT2 activities at nanomolar ranges. In vivo single oral administration of YM543 dose-dependently and significantly reduced blood glucose levels and improved glucose tolerance with a concomitant increase in urinary glucose excretion in KK Ay type 2 diabetic mice, effects that were sustained even after 12 h.
    • ¥ 12800
    8-10周
    规格
    数量
没有更多数据了